High Prevalence of Cerebral Small Vessel Disease on 7T Magnetic Resonance Imaging in Familial Hypercholesterolemia

被引:22
作者
Todate, Yusuke [1 ]
Uwano, Ikuko [2 ]
Yashiro, Satoshi [1 ]
Chida, Ai [1 ]
Hasegawa, Yutaka [1 ]
Oda, Tomoyasu [1 ]
Nagasawa, Kan [1 ]
Honma, Hiroyuki [1 ]
Sasaki, Makoto [2 ]
Ishigaki, Yasushi [1 ]
机构
[1] Iwate Med Univ, Dept Internal Med, Div Diabet Metab & Endocrinol, 19-1 Uchimaru, Morioka, Iwate 0200023, Japan
[2] Iwate Med Univ, Inst Biomed Sci, Div Ultrahigh Field MRI, Morioka, Iwate, Japan
基金
日本学术振兴会;
关键词
Familial hypercholesterolemia; Stroke; Neuroimaging; White matter hyperintensity; LDL cholesterol; PERIPHERAL ARTERIAL-DISEASE; CORONARY-HEART-DISEASE; GENERAL-POPULATION; BLOOD-PRESSURE; BRAIN-LESIONS; LIPID-LEVELS; STROKE; RISK; CHOLESTEROL; ATHEROSCLEROSIS;
D O I
10.5551/jat.48553
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aim: It remains unclear whether elevated low-density lipoprotein cholesterol (LDL-C) is a risk factor for cerebral vascular disease. Familial hypercholesterolemia (FH) is the most appropriate model for understanding the effects of excess LDL-C because affected individuals have 'inherently high levels of circulating LDL-C. To clarify the effects of hypercholesterolemia on cerebral small vessel disease (SVD), we investigated cerebrovascular damage in detail due to elevated LDL-C using high resolution brain magnetic resonance imaging (MRI) in patients with FH. Methods: Twenty-eight patients with FH and 35 healthy controls underwent 7T brain MRI. The prevalence of SVD and arterial structural changes were determined in each group. Results: The prevalence of periventricular hyperintensity (PVH) was significantly higher (control, 0% vs. FH, 14.2%, p= 0.021) and deep white matter intensity tended to be more frequent in FH patients than in controls. The prevalence of SVD in patients with forms of cerebral damage, such as lacunar infarction, PVH, deep white matter hyperintensities (DWMH), microbleeding, and brain atrophy, was significantly higher among FH patients (control, n=2, 5.7% vs. FH, n=7, 25.0%, p< 0.001, chi-square test). The tortuosity of major intracranial arteries and the signal intensity of lenticulostriate arteries were similar in the two groups. In FH patients, as the grade of PVH progressed, several atherosclerosis risk factors, such as body mass index, blood pressure, and 'glyceride level, showed ever worsening values. Conclusion: These results obtained from FH patients revealed that persistently elevated LDL-C leads to cerebral PVH. It is necessary in the management of FH to pay attention not only to the development of coronary heart disease but also to the presence of cerebral SVD.
引用
收藏
页码:1045 / 1053
页数:9
相关论文
共 39 条
[1]   Neuropsychological performance of young familial hypercholesterolemia patients [J].
Ariza, Mar ;
Cuenca, Natalia ;
Mauri, Marta ;
Angels Jurado, M. ;
Garolera, Maite .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 34 :E29-E31
[2]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[3]   FAMILIAL HYPERLIPIDEMIA IN STROKE IN THE YOUNG [J].
BANSAL, BC ;
SOOD, AK ;
BANSAL, CB .
STROKE, 1986, 17 (06) :1142-1145
[4]   Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis [J].
Barkas, Fotios ;
Elisaf, Moses ;
Milionis, Haralampos .
ATHEROSCLEROSIS, 2015, 243 (01) :60-64
[5]   Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study [J].
Beheshti, Sabina ;
Madsen, Christian M. ;
Varbo, Anette ;
Benn, Marianne ;
Nordestgaard, Borge G. .
CIRCULATION, 2018, 138 (06) :578-589
[6]   Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence [J].
Hangai, Mari ;
Takebe, Noriko ;
Honma, Hiroyuki ;
Sasaki, Atsumi ;
Chida, Ai ;
Nakano, Rieko ;
Togashi, Hirobumi ;
Nakagawa, Riyuki ;
Oda, Tomoyasu ;
Matsui, Mizue ;
Yashiro, Satoshi ;
Nagasawa, Kan ;
Kajiwara, Takashi ;
Takahashi, Kazuma ;
Takahashi, Yoshihiko ;
Satoh, Jo ;
Ishigaki, Yasushi .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (10) :1178-1187
[7]   Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017 [J].
Harada-Shiba, Mariko ;
Arai, Hidenori ;
Ishigaki, Yasushi ;
Ishibashi, Shun ;
Okamura, Tomonori ;
Ogura, Masatsune ;
Dobashi, Kazushige ;
Nohara, Atsushi ;
Bujo, Hideaki ;
Miyauchi, Katsumi ;
Yamashita, Shizuya ;
Yokote, Koutaro .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (08) :751-770
[8]   Impact of Statin Treatment on the Clinical Fate of Heterozygous Familial Hypercholesterolemia [J].
Harada-Shiba, Mariko ;
Sugisawa, Takako ;
Makino, Hisashi ;
Abe, Mitsuru ;
Tsushima, Motoo ;
Yoshimasa, Yasunao ;
Yamashita, Takahiro ;
Miyamoto, Yoshihiro ;
Yamamoto, Akira ;
Tomoike, Hitonobu ;
Yokoyama, Shinji .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (07) :667-674
[9]   Familial hypercholesterolemia, peripheral arterial disease, and stroke: A HuGE minireview [J].
Hutter, CM ;
Austin, MA ;
Humphries, SE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (05) :430-435
[10]   Risk of fatal stroke in patients with treated familial hypercholesterolemia - A prospective registry study [J].
Huxley, RR ;
Hawkins, MH ;
Humphries, SE ;
Karpe, F ;
Neil, HAW .
STROKE, 2003, 34 (01) :22-25